SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-213726
Filing Date
2024-09-05
Accepted
2024-09-05 08:38:01
Documents
15
Period of Report
2024-09-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d886086d8k.htm   iXBRL 8-K 24851
2 EX-99.1 d886086dex991.htm EX-99.1 8591
6 GRAPHIC g886086g0905025600261.jpg GRAPHIC 3709
  Complete submission text file 0001193125-24-213726.txt   160987

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lnth-20240903.xsd EX-101.SCH 2510
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20240903_lab.xml EX-101.LAB 17202
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20240903_pre.xml EX-101.PRE 10788
17 EXTRACTED XBRL INSTANCE DOCUMENT d886086d8k_htm.xml XML 3601
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 241280032
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)